Company: VRCA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-037172
Chunk: 241

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 8
Chunk 241
---
 at the beginning of the year

    69,547

    34,273

    Cash and cash equivalents at the end of the year
     
    $
    46,329

    $
    69,547

    Supplemental disclosures

    Cash paid for interest
     
    $
    7,226

    $
    3,152

    Supplemental disclosure of noncash investing and financing activities:

    Property and equipment purchases in accounts payable or accrued expenses and other current liabilities at year end
     
    $
    —

    $
    93

    Fair value of warrants issued with debt
     
    $
    —

    $
    2,041

    Right-of-use asset obtained in exchange for lease obligation
     
    $
    1,976

    $
    1,428

    Extinguishment of finance lease liability as a result of lease termination
     
    $
    1,549

    $
    —

    Extinguishment of operating lease liability as a result of lease termination
     
    $
    14

    $
    —

The accompanying notes are an integral part of these financial statements.

97

VERRICA PHARMACEUTICALS INC.